These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1127 related articles for article (PubMed ID: 26718876)
1. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries. Utkarsh D; Loretz C; Li AP Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles. Zhang J; Doshi U; Suzuki A; Chang CW; Borlak J; Li AP; Tong W Chem Biol Interact; 2016 Aug; 255():3-11. PubMed ID: 26581450 [TBL] [Abstract][Full Text] [Related]
3. Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. Li AP; Lu C; Brent JA; Pham C; Fackett A; Ruegg CE; Silber PM Chem Biol Interact; 1999 Jun; 121(1):17-35. PubMed ID: 10418968 [TBL] [Abstract][Full Text] [Related]
4. Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts. Donato MT; Lahoz A; Jiménez N; Pérez G; Serralta A; Mir J; Castell JV; Gómez-Lechón MJ Drug Metab Dispos; 2006 Sep; 34(9):1556-62. PubMed ID: 16763015 [TBL] [Abstract][Full Text] [Related]
5. Prediction of Drug-Induced Liver Injury in HepG2 Cells Cultured with Human Liver Microsomes. Choi JM; Oh SJ; Lee JY; Jeon JS; Ryu CS; Kim YM; Lee K; Kim SK Chem Res Toxicol; 2015 May; 28(5):872-85. PubMed ID: 25860621 [TBL] [Abstract][Full Text] [Related]
6. Permeabilized Cryopreserved Human Hepatocytes as an Exogenous Metabolic System in a Novel Metabolism-Dependent Cytotoxicity Assay for the Evaluation of Metabolic Activation and Detoxification of Drugs Associated with Drug-Induced Liver Injuries: Results with Acetaminophen, Amiodarone, Cyclophosphamide, Ketoconazole, Nefazodone, and Troglitazone. Wei H; Li AP Drug Metab Dispos; 2022 Feb; 50(2):140-149. PubMed ID: 34750194 [TBL] [Abstract][Full Text] [Related]
7. Puromycin-based purification of cells with high expression of the cytochrome P450 CYP3A4 gene from a patient with drug-induced liver injury (DILI). Miyata S; Saku N; Akiyama S; Javaregowda PK; Ite K; Takashima N; Toyoda M; Yura K; Kimura T; Nishina H; Nakazawa A; Kasahara M; Nonaka H; Kiyono T; Umezawa A Stem Cell Res Ther; 2022 Jan; 13(1):6. PubMed ID: 35012658 [TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells. Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399 [TBL] [Abstract][Full Text] [Related]
9. Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells. Kim DE; Jang MJ; Kim YR; Lee JY; Cho EB; Kim E; Kim Y; Kim MY; Jeong WI; Kim S; Han YM; Lee SH Toxicology; 2017 Jul; 387():1-9. PubMed ID: 28645575 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures. Yokoyama Y; Sasaki Y; Terasaki N; Kawataki T; Takekawa K; Iwase Y; Shimizu T; Sanoh S; Ohta S Biol Pharm Bull; 2018 May; 41(5):722-732. PubMed ID: 29445054 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse. Zhang J; He K; Cai L; Chen YC; Yang Y; Shi Q; Woolf TF; Ge W; Guo L; Borlak J; Tong W Chem Biol Interact; 2016 Aug; 255():45-54. PubMed ID: 27000539 [TBL] [Abstract][Full Text] [Related]
12. In vitro oxidative metabolism of cajaninstilbene Acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies. Hua X; Peng X; Tan S; Li C; Wang W; Luo M; Fu Y; Zu Y; Smyth H J Agric Food Chem; 2014 Oct; 62(43):10604-14. PubMed ID: 25272989 [TBL] [Abstract][Full Text] [Related]
13. Metabolism Comparative Cytotoxicity Assay (MCCA) and Cytotoxic Metabolic Pathway Identification Assay (CMPIA) with cryopreserved human hepatocytes for the evaluation of metabolism-based cytotoxicity in vitro: proof-of-concept study with aflatoxin B1. Li AP Chem Biol Interact; 2009 Apr; 179(1):4-8. PubMed ID: 18950609 [TBL] [Abstract][Full Text] [Related]
14. 4-Fluoromethamphetamine (4-FMA) induces in vitro hepatotoxicity mediated by CYP2E1, CYP2D6, and CYP3A4 metabolism. Roque Bravo R; Carmo H; Valente MJ; Silva JP; Carvalho F; Bastos ML; Dias da Silva D Toxicology; 2021 Nov; 463():152988. PubMed ID: 34655687 [TBL] [Abstract][Full Text] [Related]
15. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537 [TBL] [Abstract][Full Text] [Related]
16. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing. Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of cytochrome P450s enhances (+)-usnic acid cytotoxicity in primary cultured rat hepatocytes. Shi Q; Greenhaw J; Salminen WF J Appl Toxicol; 2014 Aug; 34(8):835-40. PubMed ID: 23686521 [TBL] [Abstract][Full Text] [Related]
18. Liver grafts preserved in Celsior solution as source of hepatocytes for drug metabolism studies: comparison with surgical liver biopsies. Donato MT; Serralta A; Jiménez N; Pérez G; Castell JV; Mir J; Gómez-Lechón MJ Drug Metab Dispos; 2005 Jan; 33(1):108-14. PubMed ID: 15448115 [TBL] [Abstract][Full Text] [Related]
19. 2,3,4',5-tetrahydroxystilbene-2-O-β-D-glucoside exacerbates acetaminophen-induced hepatotoxicity by inducing hepatic expression of CYP2E1, CYP3A4 and CYP1A2. Xu S; Liu J; Shi J; Wang Z; Ji L Sci Rep; 2017 Nov; 7(1):16511. PubMed ID: 29184146 [TBL] [Abstract][Full Text] [Related]